Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 113
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Breaking: U.S. Government Taps Mark Cuban’s Company to Develop Ibogaine for PTSD; Commits to Fund $20M Real-World Evidence Network
220 Patients or 20,000? Clinics Split on Psychedelics’ First Year
Robert Rush: Emergency Scheduling, 7-OH, and the War on Research
Breaking: Compass Files Psilocybin for TRD New Drug Application with FDA
The Problems We Will Be Lucky to Have
MIND CURE HEALTH INC. ANNOUNCES CLOSING OF THE FIRST TRANCHE OF...
MIND CURE AND LNG ENERGY GROUP PROVIDE UPDATE ON PREVIOUSLY ANNOUNCED...
BetterLife Continues Progress on BETR-001 IND-Enabling Studies
Numinus to Participate in the Healthcare Virtual Conference Presented by Maxim...
Are You Attending PS2023? Here’s Where to Find Psychedelics Today in...
COMPASS Pathways’ key patents upheld by the US Patent and Trademark...
Algernon Pharmaceuticals to Present Phase 2 Ifenprodil Cough Data at the...
Cedar Clinical Research, by Numinus, the top enrolling clinical research site...
Algernon NeuroScience Announces Successful Completion of Highest Planned Single Dose in...
Psychedelics Weekly – Drug Testing and Harm Reduction, Ketamine vs. ECT,...
Load more